An opioid analgesic that is used as an adjunct in anesthesia, in balanced anesthesia, and as a primary anesthetic agent.
Sufentanil has been studied across 17 research domains including 💊 Pain, 😴 Sleep, ❤️ Cardiovascular, 🧠 Focus & Attention, 🔬 Oncology. The primary research focus is 💊 Pain with 56% of studies addressing this area.
The following compounds share molecular targets with Sufentanil, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Sufentanil is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.